GREGORY SARGEN
CIK 1227835 · CFO & EVP, Corp. Dev. · last filed 2026-06-16
GREGORY SARGEN is a CFO & EVP, Corp. Dev. who has filed 49 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for TARA, was dated Jun 16, 2026. Across all open-market trades the lifetime net is −$23.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $123.4K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$123.4K
5
49
-$23.46M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TARA | Director | 31,000 | $3.98 | $123.4K | $0 | 8 | 2026-06-16 |
| Avid Bioservices, Inc. (CDMO) Delisted | Director | 36,368 | $12.49 | $454.2K | -$141.9K | 5 | 2024-12-17 |
| Avid Bioservices, Inc. (CDMOP) Delisted | Director | — | $25.06 | — | $0 | 3 | 2020-12-16 |
| CAMBREX CORP (CBM) Delisted | CFO & EVP, Corp. Dev. | 0 | — | — | -$23.31M | 31 | 2019-12-05 |
| Avid Bioservices, Inc. (PPHMP) Delisted | Director | — | — | — | $0 | 1 | 2017-11-29 |
Recent Filings
49 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-16 | TARA | Grant (A) | — | $0 | EDGAR |
| 2025-06-13 | TARA | Grant (A) | — | $0 | EDGAR |
| 2025-02-07 | — | Disp (D) | −36,368 | $0 | |
| 2024-12-17 | Avid Bioservices, Inc. (CDMO) Delisted | Mixed | +26,756 | $0 | EDGAR |
| 2024-06-10 | TARA | Grant (A) | — | $0 | EDGAR |
| 2023-12-18 | Avid Bioservices, Inc. (CDMO) Delisted | Mixed | +9,612 | $0 | EDGAR |
| 2023-06-08 | TARA | Grant (A) | — | $0 | EDGAR |
| 2023-04-12 | Avid Bioservices, Inc. (CDMO) Delisted | Sell (S) | −7,011 | -$141.9K | EDGAR |
| 2022-12-16 | Avid Bioservices, Inc. (CDMO) Delisted | Mixed | +4,632 | $0 | EDGAR |
| 2022-06-09 | TARA | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.